These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7910656)

  • 21. Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia.
    Hamidah A; Arini MI; Zarina AL; Zulkifli SZ; Jamal R
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):900-5. PubMed ID: 19058587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of GH deficiency and beta-thalassemia.
    Smacchia MP; Mercuri V; Antonetti L; Bassotti G; D'Amico T; Pietrobono D; Gargiulo P
    Minerva Endocrinol; 2012 Jun; 37(2):201-9. PubMed ID: 22691893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-thalassemia and pulmonary function.
    Piatti G; Allegra L; Ambrosetti U; Cappellini MD; Turati F; Fiorelli G
    Haematologica; 1999 Sep; 84(9):804-8. PubMed ID: 10477453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination.
    Kattamis CA; Kattamis AC
    Semin Hematol; 1995 Oct; 32(4):269-79. PubMed ID: 8560284
    [No Abstract]   [Full Text] [Related]  

  • 25. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A; Kati M; Tsironi M; Polonifi E; Farmakis D
    Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of hematologic treatment on the growth and puberty of children with thalassemia major].
    Pomarède R; Girot R; Constant S; Rappaport R
    Arch Fr Pediatr; 1984 Apr; 41(4):255-9. PubMed ID: 6477042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of the determination of somatotropin in delayed growth].
    Franchimont P; Deconinck B
    Sem Hop; 1969 Nov; 45(48):3009-14. PubMed ID: 4312498
    [No Abstract]   [Full Text] [Related]  

  • 28. The management of patients with Cooley's anemia: transfusions and splenectomy.
    Piomelli S
    Semin Hematol; 1995 Oct; 32(4):262-8. PubMed ID: 8560283
    [No Abstract]   [Full Text] [Related]  

  • 29. Growth and growth hormone secretion at puberty: the role of gonadal steroid hormones.
    Rogol AD
    Acta Paediatr Suppl; 1992 Sep; 383():15-20; discussion 21. PubMed ID: 1458010
    [No Abstract]   [Full Text] [Related]  

  • 30. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
    Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
    Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulant system activity in splenectomized versus non-splenectomized Iranian patients with beta-thalassemia major.
    Rashidi A; Alavi S; Arzanian MT; Ahmadinejad M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):645-7. PubMed ID: 18092257
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the efficacy of chelation therapy with deferoxamine in patients with thalassemia major].
    Rodríguez Galindo C; Ortega Aramburu JJ; Alonso JL; Albisu M; Casaldáliga J; Díaz de Heredia C; Olivé T; Bastida P
    Med Clin (Barc); 1994 May; 102(19):721-4. PubMed ID: 8041200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth and puberty in thalassemia major.
    Saka N; Sükür M; Bundak R; Anak S; Neyzi O; Gedikoğlu G
    J Pediatr Endocrinol Metab; 1995; 8(3):181-6. PubMed ID: 8521192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chelation therapy and cardiac status in young patients with thalassemia major.
    Roodpeyma S; Alebouye M; Kamali Z
    J Trop Pediatr; 2000 Jun; 46(3):179. PubMed ID: 10893922
    [No Abstract]   [Full Text] [Related]  

  • 35. Platyspondyly in treated beta-thalassemia.
    Orzincolo C; Castaldi G; Scutellari PN
    Eur J Radiol; 1994 May; 18(2):129-33. PubMed ID: 8055985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy for beta-thalassemia--a paradigm for the treatment of genetic disorders.
    Dover GJ; Valle D
    N Engl J Med; 1994 Sep; 331(9):609-10. PubMed ID: 8047089
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anomalies of the masticatory apparatus in beta-thalassemia. The present status after transfusion and iron-chelating therapy].
    Scutellari PN; Orzincolo C; Andraghetti D; Gamberini MR
    Radiol Med; 1994 Apr; 87(4):389-96. PubMed ID: 8190919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deferoxamine in thalassemia major.
    Cazzola M; Locatelli F; De Stefano P
    N Engl J Med; 1995 Jan; 332(4):271-2; author reply 272-3. PubMed ID: 7808503
    [No Abstract]   [Full Text] [Related]  

  • 39. [Relations between hypothalamo-hypophyseal-gonadal function and hemoglobin level in the polytransfused thalassemic child].
    Zappulla F; Balsamo A; Tassinari D; Marsciani A; Bergamaschi R; Berni M; Cacciari E
    Minerva Pediatr; 1981 Apr; 33(7):317-22. PubMed ID: 7017377
    [No Abstract]   [Full Text] [Related]  

  • 40. Contrast sensitivity function in patients with beta-thalassemia major.
    Gartaganis SP; Zoumbos N; Koliopoulos JX; Mela EK
    Acta Ophthalmol Scand; 2000 Oct; 78(5):512-5. PubMed ID: 11037904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.